In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

For the current quarter, Pfizer is expected to post earnings of $0.48 per share, indicating a change of +380% from the year-ago quarter. The Zacks Consensus Estimate has changed -3.7% over the last 30 ...

If generating more passive income is one of your New Year's resolutions, you have plenty of options for achieving the goal.

U.S. stock futures were rising early Tuesday as the market grapples with possible repercussions from any tariffs imposed by President-elect Donald Trump. Trump quashed speculation that he would pare ...

It's important to keep in mind that Buffett's words and actions don't always follow the path of the majority. This top ...

On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.59 which represents a decrease of $-0.02 or -0.08% from the prior close of $26.61. The stock opened at $26.7 and touched a low of ...

The stock market is starting to put its December slide behind it. The Dow was up 331 points, or 0.8%, in midday trading. The S&P 500 was up 1.2%. The Nasdaq Composite gained 1.8%. Even more ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Pfizer Inc. (NYSE:PFE – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen ratings ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) were down 0.2% during trading on Friday . The company traded as low as $26 ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...